Skip to content
May 06, 2024

Equity.Guru

Investment information for the new generation

Search

New Drug Application

Medexus Pharmaceuticals (MDP.T) announced today that medac GmbH, the Company’s licensor for treosulfan, has received a Complete Response Letter (CRL) from the Food and Drug Administration (FDA) in response…